GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clarity Medical Group Holding Ltd (HKSE:01406) » Definitions » ROE %

Clarity Medical Group Holding (HKSE:01406) ROE % : -51.79% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Clarity Medical Group Holding ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Clarity Medical Group Holding's annualized net income for the quarter that ended in Mar. 2024 was HK$-111.5 Mil. Clarity Medical Group Holding's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was HK$215.4 Mil. Therefore, Clarity Medical Group Holding's annualized ROE % for the quarter that ended in Mar. 2024 was -51.79%.

The historical rank and industry rank for Clarity Medical Group Holding's ROE % or its related term are showing as below:

HKSE:01406' s ROE % Range Over the Past 10 Years
Min: -33.78   Med: 20.38   Max: 77.92
Current: -32.95

During the past 6 years, Clarity Medical Group Holding's highest ROE % was 77.92%. The lowest was -33.78%. And the median was 20.38%.

HKSE:01406's ROE % is ranked worse than
71.73% of 803 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs HKSE:01406: -32.95

Clarity Medical Group Holding ROE % Historical Data

The historical data trend for Clarity Medical Group Holding's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Medical Group Holding ROE % Chart

Clarity Medical Group Holding Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE %
Get a 7-Day Free Trial 32.72 35.20 8.03 -1.24 -33.78

Clarity Medical Group Holding Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only 2.36 6.02 -8.39 -16.00 -51.79

Competitive Comparison of Clarity Medical Group Holding's ROE %

For the Medical Instruments & Supplies subindustry, Clarity Medical Group Holding's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clarity Medical Group Holding's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clarity Medical Group Holding's ROE % distribution charts can be found below:

* The bar in red indicates where Clarity Medical Group Holding's ROE % falls into.



Clarity Medical Group Holding ROE % Calculation

Clarity Medical Group Holding's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=-75.793/( (259.284+189.522)/ 2 )
=-75.793/224.403
=-33.78 %

Clarity Medical Group Holding's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=-111.548/( (241.252+189.522)/ 2 )
=-111.548/215.387
=-51.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


Clarity Medical Group Holding  (HKSE:01406) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-111.548/215.387
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-111.548 / 178.646)*(178.646 / 266.532)*(266.532 / 215.387)
=Net Margin %*Asset Turnover*Equity Multiplier
=-62.44 %*0.6703*1.2375
=ROA %*Equity Multiplier
=-41.85 %*1.2375
=-51.79 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-111.548/215.387
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-111.548 / -117.202) * (-117.202 / -57.602) * (-57.602 / 178.646) * (178.646 / 266.532) * (266.532 / 215.387)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9518 * 2.0347 * -32.24 % * 0.6703 * 1.2375
=-51.79 %

Note: The net income data used here is two times the semi-annual (Mar. 2024) net income data. The Revenue data used here is two times the semi-annual (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Clarity Medical Group Holding ROE % Related Terms

Thank you for viewing the detailed overview of Clarity Medical Group Holding's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarity Medical Group Holding Business Description

Traded in Other Exchanges
N/A
Address
9 Queen’s Road Central, Room 1302, 13th Floor, Hong Kong, HKG
Clarity Medical Group Holding Ltd is committed to providing comprehensive and professional ophthalmic services for patients with various eye conditions. It operates two medical centers in Central and Mongkok. The medical centers are equipped with medical instruments and surgical equipment which allows performing various ophthalmic examinations, treatments, and surgeries for patients.
Executives
Prime Sage International Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Ultimate Bliss Limited 2307 Founder of a discretionary trust who can infl
Tse Wai Ip 2307 Founder of a discretionary trust who can infl
Cheng Chi Heng 2101 Beneficial owner
3w Partners Fund I L.p. 2201 Interest of corporation controlled by you
3w Partners Gp Limited 2201 Interest of corporation controlled by you
3w Partners Holdings Limited 2201 Interest of corporation controlled by you
Clear Lead Ventures Limited 2101 Beneficial owner
Goh Lu Hong 2501 Other
Chan Hoi Hin William 2501 Other
Wuxi Apptec (hong Kong) Limited
Wuxi Apptec Co., Ltd.

Clarity Medical Group Holding Headlines

No Headlines